The novel therapy of this peptide represents a major breakthrough in the management of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects two pathways – GLP-1 and GIP – resulting in enhanced https://tirzepatidepeptide685523.mpeblog.com/76220906/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment